Literature DB >> 3196286

A catalytically active high-Mr form of human cathepsin B from sputum.

D J Buttle1, B C Bonner, D Burnett, A J Barrett.   

Abstract

A cysteine proteinase from purulent sputum was partially purified by a method involving affinity chromatography on Sepharose-aminohexanoylphenylalanylglycinaldehyde semicarbazone. It was immunologically related to lysosomal cathepsin B from human liver and was similar in many, but not all, other aspects. It was catalytically active, as demonstrated by active-site-directed radioiodination, and hydrolysed three cathepsin B substrates, two with Km values similar to those of lysosomal cathepsin B. In addition, the rates of inactivation of the sputum and lysosomal forms of the enzyme by L-3-carboxy-2,3-transepoxypropionyl-leucylamido(4-guanidino) butane (Compound E-64) were very similar. However, the sputum enzyme differed from lysosomal cathepsin B in the following respects. Inhibition by chicken cystatin was much weaker for sputum cathepsin B than for the lysosomal enzyme. Sputum cathepsin B had greater stability at pH 7.5 and a higher apparent Mr, even after deglycosylation, than lysosomal cathepsin B. We conclude that the form of cathepsin B found in sputum is probably a truncated form of human procathepsin B, with some differences in properties that could be of physiological importance.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3196286      PMCID: PMC1135140          DOI: 10.1042/bj2540693

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  32 in total

1.  Interrelationship of active and latent secreted human cathepsin B precursors.

Authors:  J S Mort; A D Recklies
Journal:  Biochem J       Date:  1986-01-01       Impact factor: 3.857

2.  Purification of cathepsin B by a new form of affinity chromatography.

Authors:  D H Rich; M A Brown; A J Barrett
Journal:  Biochem J       Date:  1986-05-01       Impact factor: 3.857

3.  Biosynthesis of cathepsin B in cultured normal and I-cell fibroblasts.

Authors:  H Hanewinkel; J Glössl; H Kresse
Journal:  J Biol Chem       Date:  1987-09-05       Impact factor: 5.157

4.  A linear equation that describes the steady-state kinetics of enzymes and subcellular particles interacting with tightly bound inhibitors.

Authors:  P J Henderson
Journal:  Biochem J       Date:  1972-04       Impact factor: 3.857

5.  Monoclonal antibodies to rabbit liver cathepsin B.

Authors:  R J Wardale; R A Maciewicz; D J Etherington
Journal:  Biosci Rep       Date:  1986-07       Impact factor: 3.840

6.  The design of peptidyldiazomethane inhibitors to distinguish between the cysteine proteinases calpain II, cathepsin L and cathepsin B.

Authors:  C Crawford; R W Mason; P Wikstrom; E Shaw
Journal:  Biochem J       Date:  1988-08-01       Impact factor: 3.857

7.  Specificity of activated human protein C.

Authors:  S R Stone; J Hofsteenge
Journal:  Biochem J       Date:  1985-09-01       Impact factor: 3.857

8.  Human cathepsin B1. Purification and some properties of the enzyme.

Authors:  A J Barrett
Journal:  Biochem J       Date:  1973-04       Impact factor: 3.857

9.  Nucleotide and predicted amino acid sequences of cloned human and mouse preprocathepsin B cDNAs.

Authors:  S J Chan; B San Segundo; M B McCormick; D F Steiner
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

10.  Species variants of cathepsin L and their immunological identification.

Authors:  R W Mason
Journal:  Biochem J       Date:  1986-11-15       Impact factor: 3.857

View more
  6 in total

1.  Proteolytic processing and glycosylation of cathepsin B. The role of the primary structure of the latent precursor and of the carbohydrate moiety for cell-type-specific molecular forms of the enzyme.

Authors:  L Mach; K Stüwe; A Hagen; C Ballaun; J Glössl
Journal:  Biochem J       Date:  1992-03-01       Impact factor: 3.857

2.  Enhanced tumor retention of NTSR1-targeted agents by employing a hydrophilic cysteine cathepsin inhibitor.

Authors:  Wei Fan; Wenting Zhang; Sameer Alshehri; Trey R Neeley; Jered C Garrison
Journal:  Eur J Med Chem       Date:  2019-05-25       Impact factor: 6.514

3.  Expression of cathepsin P mRNA, protein and activity in the rat choriocarcinoma cell line, Rcho-1, during giant cell transformation.

Authors:  M Hassanein; B D Korant; G Lu; R W Mason
Journal:  Placenta       Date:  2007-01-10       Impact factor: 3.481

4.  Human sputum cathepsin B degrades proteoglycan, is inhibited by alpha 2-macroglobulin and is modulated by neutrophil elastase cleavage of cathepsin B precursor and cystatin C.

Authors:  D J Buttle; M Abrahamson; D Burnett; J S Mort; A J Barrett; P M Dando; S L Hill
Journal:  Biochem J       Date:  1991-06-01       Impact factor: 3.857

5.  Pericellular mobilization of the tissue-destructive cysteine proteinases, cathepsins B, L, and S, by human monocyte-derived macrophages.

Authors:  V Y Reddy; Q Y Zhang; S J Weiss
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-25       Impact factor: 11.205

6.  Cathepsin Inhibition Prevents Autophagic Protein Turnover and Downregulates Insulin Growth Factor-1 Receptor-Mediated Signaling in Neuroblastoma.

Authors:  Mehrnoosh Soori; Guizhen Lu; Robert W Mason
Journal:  J Pharmacol Exp Ther       Date:  2015-12-10       Impact factor: 4.030

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.